openPR Logo
Press release

Peraso Inc. (NASDAQ: PRSO): A Critical Enabler Positioned for AI, 5G, and Telecom Growth - More Stock Pure-Plays inside....

02-11-2025 11:00 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Peraso Inc. (NASDAQ: PRSO): A Critical Enabler Positioned

Peraso Inc. (NASDAQ: PRSO) is a high-upside technology stock benefiting from the explosive growth of AI, 5G, and edge comp uting. As next-generation networks increasingly rely on high-bandwidth, low-latency solutions, Peraso's 60 GHz mmWave technology is a crucial enabler of this transformation.

Financial Metrics & Industry Comparisons:

* PRSO's Market Cap: Still under $50 million, a fraction of competitors in the 5G and semiconductor industries, suggesting substantial upside potential.
* Industry Growth Projection: The global mmWave market is projected to reach $20+ billion by 2030, presenting a massive runway for expansion.
* Institutional Investment Potential: Larger tech funds are increasingly shifting focus to AI-driven telecom and semiconductor stocks-an indicator that PRSO could see increased institutional interest as it gains visibility.

Key Investment Takeaways:

* Scalability: PRSO's mmWave solutions are built for mass deployment, offering high-performance AI, telecom, and industrial networking applications.
* Breakout Potential: With low float and increasing daily volume, PRSO remains one of the most volatile and high-reward plays in the small-cap tech sector.
* Future-Proof Technology: PRSO's 3 Gbps mmWave technology outperforms traditional connectivity solutions, positioning it at the forefront of the AI and telecom infrastructure revolution.

With its unique market positioning, expanding applications, and increasing investor awareness, PRSO is emerging as one of the most compelling investment opportunities in AI-powered telecom and defense technology.

Technical Analysis: As of February 11, 2025, Peraso's stock is trading at $0.7950, reflecting a slight decrease of 0.06842% from the previous close. The 50-day exponential moving average is $1.08, while the 20-day exponential moving average is $1.01, both indicating a 'Sell' signal suggesting the reversal back to an upward trend.Also, Peraso has 20 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).

Other Stocks to Watch:

* Lipella Pharmaceuticals (NASDAQ: LIPO) - A biotech stock with promising developments in urology-focused therapies.
* Lichen China Limited (NASDAQ: LICN) - A financial consulting firm gaining attention in the fintech space.
* SelectQuote (NYSE: SLQT) - A tech-driven insurance platform showing resilience amid sector shifts.
* Kaival Brands (NASDAQ: KAVL) finalizing business combination in February 2025, trading at $1.43 (+7.52%), with $13.09M in revenue (FY 2023), and exclusive global rights to Bidi Stick, positioning it as a small-cap stock to watch in the evolving ENDS market.

As small-cap stocks gain momentum, PRSO, LIPO, LICN, SLQT, and KAVL offer diverse opportunities across tech, media, energy, and biotech, making them stocks to watch in the evolving market landscape.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=peraso-inc-nasdaq-prso-a-critical-enabler-positioned-for-ai-5g-and-telecom-growth-more-stock-pureplays-inside]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peraso Inc. (NASDAQ: PRSO): A Critical Enabler Positioned for AI, 5G, and Telecom Growth - More Stock Pure-Plays inside.... here

News-ID: 3863538 • Views:

More Releases from ABNewswire

New Edition 2026 The New Edition Way Tour Tickets: Discounted with Promo Code CITY10 at CapitalCityTickets.com
New Edition 2026 The New Edition Way Tour Tickets: Discounted with Promo Code CI …
See New Edition live on The New Edition Way Tour in 2026! Score discounted tickets with promo code CITY10 at CapitalCityTickets.com. Check full tour dates, secure the best seats, and access exclusive deals. Don't miss your chance to experience this legendary R&B group live-grab your tickets now and save big on an unforgettable concert event. R&B legends unite! New Edition, alongside powerhouse special guests Boyz II Men and Toni Braxton, is
Sam Barber 2026 The American Route Tour Tickets: Discounted with Promo Code CITY10 at CapitalCityTickets.com
Sam Barber 2026 The American Route Tour Tickets: Discounted with Promo Code CITY …
See Sam Barber live on The American Route Tour in 2026! Grab discounted tickets with promo code CITY10 at CapitalCityTickets.com. Check full tour dates, secure the best seats, and enjoy exclusive deals. Don't miss your chance to experience Sam Barber's unforgettable performance-buy your tickets now and save big on this must-see tour. Country music fans, the wait is over-rising star Sam Barber is hitting the road in 2026 with his highly
Best Reddit Marketing Agency (2026): Odd Angles Media Voted #1 By BrightVerge Research Group
Best Reddit Marketing Agency (2026): Odd Angles Media Voted #1 By BrightVerge Re …
Odd Angles Media Awarded Best Reddit Marketing Agency (2026) by Independent Research Firm (BrightVerge Research Group) Odd Angles Media has been ranked the best Reddit marketing agency in 2026 by BrightVerge Research Group, an independent market research firm specializing in digital channel effectiveness and buyer behavior analysis. The study evaluated six provider categories - including full-service social agencies, traditional SEO firms, and Reddit specialists - across criteria tied to durable visibility outcomes:
Sickle Cell Disease Market: High-Growth Opportunities for Investors to 2034 - DelveInsight | BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharma, Beam Therapeutics, Graphite Bio, Roche
Sickle Cell Disease Market: High-Growth Opportunities for Investors to 2034 - De …
The Key Sickle Cell Disease Companies in the market include - BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharmaceuticals, Beam Therapeutics Inc., Graphite Bio, Roche, Quercis Pharma, Editas Medicin, Pfizer, Emmaus Medical, Inc, Vertex Pharmaceuticals, CRISPR therapeutics, Bluebird Bio, Pfizer, Novo Nordisk, Agios Pharmaceuticals, Alexion Pharmaceuticals, Takeda, Prolong Pharmaceuticals, Roche, CSL Behring, Fulcrum Therapeutics, Sana Biotechnology, and others DelveInsight's comprehensive market research provides critical insights into such market trends, enabling stakeholders to

All 5 Releases


More Releases for PRSO

Premarket Small-Caps Surge: PRSO, VEEE, HOUR, LOOP - More Stocks Inside
U.S. Markets: Today's premarket session has seen explosive moves across several small-cap names, driven by takeover bids, AI-powered product launches, e-commerce strength, and blockchain treasury initiatives. Peraso Inc. (NASDAQ: PRSO) shares soared over 85% premarket to $1.50, leading all movers, after Mobix Labs (NASDAQ: MOBX) sweetened its unsolicited takeover bid. The semiconductor firm, which initially offered an all-stock deal valuing Peraso at $1.20 per share, has now added a cash component
Peraso (NASDAQ: PRSO) Volume Surges on Takeover News - More Stocks Inside
Mobix Labs, Inc. (NASDAQ: MOBX) has launched an unsolicited, non-binding proposal to acquire Peraso Inc. (NASDAQ: PRSO) in a stock-for-stock deal offering Peraso shareholders a 20% premium over the company's 30-day average share price. The proposed merger would create a stronger player in the high-growth mmWave, defense, and 5G semiconductor sectors-combining Mobix's $10.7M revenue base and ~450% YoY growth with Peraso's accelerating mmWave performance. The combined company is expected to generate
Thanksgiving Week Oversold Stocks to Watch:CRDL, QBTS, PRSO, RGTI & More!
As Thanksgiving approaches, investors are turning their attention to oversold stocks across some of the most innovative sectors in the market. This week's focus spans industries like biotechnology, healthcare, wireless technology, quantum computing and artificial intelligence-each offering promising opportunities despite recent declines in stock prices. With advancements in these cutting-edge fields continuing to shape the future, these undervalued stocks could provide high-reward potential for those looking to capitalize on market
5 Must-Watch Stocks Under $5: NIXX, PRSO, VSME, BREA, STAF
As industries across the globe continue to evolve and innovate, these five companies are leading the charge with cutting-edge strategies, groundbreaking technologies, and strategic acquisitions, each poised to make a lasting impact in their respective fields. Nixxy (NASDAQ: NIXX) has issued a strategic update on its acquisition plans, targeting traditional markets for transformation using cutting-edge technology and data analytics. With a focus on acquiring businesses generating revenues between $10 million and
Early Market Movers: PRSO, PNPN.V, MLGO, API, AGBA more inside - Today's Watchli …
Thursday's after-hours trading is buzzing with stocks showing strong momentum. As markets shift, investors should watch these key players making strides across industries. Here's a quick look at recent movers: Peraso Inc. (NASDAQ: PRSO) continues to gain traction with investors after securing a major military contract for its Perspectus module, which utilizes advanced 60 GHz mmWave RF technology to improve battlefield communications. Peraso's expansion into Asia, with high-speed internet systems for
Spotlighting Unexplored Stocks in Focus: NKGN, INBS, BTBT, PRSO, MGOL
Investors frequently search for stocks of companies with improving operational performance. This article offers an in-depth look at five companies that have recently made significant progress. NKGen Biotech Inc. (NASDAQ: NKGN): A clinical-stage biotech firm, NKGen Biotech is focused on developing and commercializing allogeneic, autologous, and CAR-NK natural killer cell therapies. On May 20, the company announced that its cryopreserved autologous, enhanced, and expanded SNK01 had received clearance from the Safety